FDA Pilot Program To Consider Liver-On-Chip Technology

FDA’s Center for Drug Evaluation and Research (CDER) has accepted the first investigational organ-on-chip technology into its pilot program for innovative drug discovery tech, a liver-chip model intended to study drug-induced liver injury for certain drug candidates. A organ-on-a-chip model is a 3D in vitro device that mimics a human organ's tissue and physiological functions, a technology drug developers hope can help identify problems before human trials and perhaps eventually act as a substitute for animal testing. CDER announced last...